Hu Shuqi,Han Yijiang,Zhao Xiaoxia,et al.Prognostic value of preoperative serum levels of MMPs in children of biliary atresia[J].Journal of Clinical Pediatric Surgery,2024,(08):723-728.[doi:10.3760/cma.j.cn101785-202405079-005]
Ⅲ型胆道闭锁患儿术前基质金属蛋白酶水平与Kasai手术后预后的相关性研究
- Title:
- Prognostic value of preoperative serum levels of MMPs in children of biliary atresia
- Keywords:
- Biliary Atresia; Matrix Metalloproteinases; Hepatic Fibrosis; Jaundice; Cholangitis; Survival Rate; Correlation of Data
- 摘要:
- 目的 探索Ⅲ型胆道闭锁患儿术前血清基质金属蛋白酶(matrix metalloproteinases,MMPs)系列蛋白与肝纤维化程度及Kasai术后黄疸清除率、早期胆管炎和中长期自体肝生存的相关性,寻找预测胆道闭锁Kasai手术预后的相关因子。 方法 回顾性分析2017年3月至2018年6月浙江大学医学院附属儿童医院新生儿外科确诊为Ⅲ型胆道闭锁并行Kasai手术的患儿术前血清MMPs蛋白水平,收集患儿术后肝脏病理、术后3个月黄疸消退情况、术后早期胆管炎情况以及术后5年自体肝生存情况。分析不同预后组别患儿术前血清MMPs系列蛋白水平,评估术前血清MMPs蛋白与预后的关系。 结果 本研究共纳入38例患儿,男22例、女16例,3例术中造影确诊为Ⅲ型胆道闭锁后家属拒绝行Kasai术,仅行肝脏活检术;35例确诊后行Kasai术及肝脏活检术,术后均获随访,其中6例于术后1年内行肝移植手术,2例因胆道闭锁相关并发症死亡,27例随防5年以上均自体肝存活。术后3个月黄疸消退组和黄疸未消退组比较、自体肝存活组和非自体肝存活组比较,术前血清MMPs系列蛋白水平差异均无统计学意义(P＞0.05)。早期胆管炎组术前血清MMP-7为(29 967.89±15 079.03)pg/mL,无早期胆管炎组为(15 071.77±10 988.75)pg/mL,差异有统计学意义(t=2.978,P<0.05)。轻度肝纤维化组术前血清MMP-7为9 103.31(4 603.54,16 759.18)pg/mL,重度肝纤维化组为20 288.52(11 146.71,28 581.65)pg/mL,差异有统计学意义(Z=-2.285,P<0.05)。轻度肝纤维化组术前血清MMP-13为1 396.81(1 295.41,1 748.79)pg/mL,重度肝纤维化组为1 193.47(1 013.33,1 485.17)pg/mL,差异有统计学意义(Z=-1.972,P<0.05)。 结论 胆道闭锁患儿术前血清MMP-7和MMP-13与Kasai术后早期胆管炎以及肝脏纤维化程度相关,可望作为预测胆道闭锁部分预后指标的一项潜在因子。
- Abstract:
- Objective To explore the correlation between preoperative serum matrix metalloproteinases (MMPs) levels and liver fibrosis, as well as the jaundice clearance rate, early cholangitis, and medium-to-long-term native liver survival following the Kasai procedure in children with Type Ⅲ biliary atresia, in order to identify predictive factors for the prognosis of biliary atresia after Kasai surgery.Methods A retrospective analysis was conducted on the preoperative serum MMPs protein levels of children diagnosed with Type Ⅲ biliary atresia who underwent the Kasai procedure at the Department of Neonatal Surgery, Children’s Hospital, Zhejiang University School of Medicine,procedure from March 2017 to June 2018. Postoperative data included liver pathology, jaundice resolution at 3 months, early cholangitis, and 5-year native liver survival. Serum MMPs levels were analyzed in relation to different prognostic outcomes.Results A total of 38 children were included in this study, including 22 males and 16 females. 3 children, diagnosed with Type Ⅲ biliary atresia intraoperatively, had their families refuse the Kasai procedure and only underwent liver biopsy. Of the 35 patients who proceeded with the Kasai procedure and liver biopsy, 6 underwent liver transplantation within 1 year post-surgery, 2 died due to biliary atresia-related complications, and 27 survived with native liver for over 5 years. There were no statistically significant differences in preoperative serum MMPs levels between the jaundice resolution and non-resolution groups, or between the native liver survival and non-survival groups. However, preoperative serum MMP-7 levels were significantly higher in the early cholangitis group (29 967.89±15 079.03 pg/mL) compared to the non-cholangitis group (15 071.77±10 988.75 pg/mL)(t=2.978,P<0.05). For liver fibrosis, MMP-7 levels were higher in the severe fibrosis group compared to the mild fibrosis group (Z=-2.285,P<0.05). MMP-13 levels were lower in the severe fibrosis group compared to the mild fibrosis group (Z=-1.972,P<0.05).Conclusions Preoperative serum MMP-7 and MMP-13 levels are associated with early cholangitis and the degree of liver fibrosis after Kasai surgery in children with biliary atresia, and may as potential prognostic markers.
参考文献/References:
[1] Brindley SM,Lanham AM,Karrer FM,et al.Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells[J].Hepatology,2012,55(4):1130-1138.DOI:10.1002/hep.24807.
[2] Asai A,Miethke A,Bezerra JA.Pathogenesis of biliary atresia:defining biology to understand clinical phenotypes[J].Nat Rev Gastroenterol Hepatol,2015,12(6):342-352.DOI:10.1038/nrgastro.2015.74.
[3] Kumar L,Bisen M,Khan A,et al.Role of matrix metalloproteinases in musculoskeletal diseases[J].Biomedicines,2022,10(10):2477.DOI:10.3390/biomedicines10102477.
[4] Rangasamy L,Geronimo BD,Ortín I,et al.Molecular imaging probes based on matrix metalloproteinase inhibitors (MMPIs)[J].Molecules,2019,24(16):2982.DOI:10.3390/molecules24162982.
[5] 王培,冯杰雄.胆道闭锁术后胆管炎抗生素分级治疗的多中心研究方案[J].临床小儿外科杂志,2019,18(11):922-926.DOI:10.3969/j.issn.1671-6353.2019.11.006. Wang P,Feng JX.The antibiotics treatment of cholangitis post-Kasai portoenterostomy:a multi-center study protocol[J].DOI:10.3969/j.issn.1671-6353.2019.11.006.
[6] 周李,金龙,李桂生,等.胆小管增生诱导胆道闭锁早期肝纤维化[J].中华小儿外科杂志,2005,26(6):281-284.DOI:10.3760/cma.j.issn.0253-3006.2005.06.001. Zhou L,Jin L,Li GS,et al.Ductal proliferation induces liver fibrosis in the early stage of biliary atresia[J].Chin J Pediatr Surg,2005,26(6):281-284.DOI:10.3760/cma.j.issn.0253-3006.2005.06.001.
[7] Lertudomphonwanit C,Mourya R,Fei L,et al.Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia[J].Sci Transl Med,2017,9(417):eaan8462.DOI:10.1126/scitranslmed.aan8462.
[8] de Almeida LGN,Thode H,Eslambolchi Y,et al.Matrix metalloproteinases:from molecular mechanisms to physiology,pathophysiology,and pharmacology[J].Pharmacol Rev,2022,74(3):712-768.DOI:10.1124/pharmrev.121.000349.
[9] 葛亮,詹江华.胆道闭锁肝纤维化与自体肝生存关系的研究进展[J].临床小儿外科杂志,2020,19(2):171-175.DOI:10.3969/j.issn.1671-6353.2020.02.016. Ge L,Zhan JH.Relationship between liver fibrosis and native liver survival in infants with biliary atresia[J].J Clin Ped Sur,2020,19(2):171-175.DOI:10.3969/j.issn.1671-6353.2020.02.016.
[10] Jiang JY,Wang JF,Shen Z,et al.Serum MMP-7 in the diagnosis of biliary atresia[J].Pediatrics,2019,144(5):e20190902.DOI:10.1542/peds.2019-0902.
[11] Nomden M,Beljaars L,Verkade HJ,et al.Current concepts of biliary atresia and matrix metalloproteinase-7:a review of literature[J].Front Med (Lausanne),2020,7:617261.DOI:10.3389/fmed.2020.617261.
[12] Endo H,Niioka M,Sugioka Y,et al.Matrix metalloproteinase-13 promotes recovery from experimental liver cirrhosis in rats[J].Pathobiology,2011,78(5):239-252.DOI:10.1159/000328841.
[13] Prystupa A,Szpetnar M,Boguszewska-Czubara A,et al.Activity of MMP1 and MMP13 and amino acid metabolism in patients with alcoholic liver cirrhosis[J].Med Sci Monit,2015,21:1008-1014.DOI:10.12659/MSM.892312.
[14] Nissinen L,K?h?ri VM.Matrix metalloproteinases in inflammation[J].Biochim Biophys Acta,2014,1840(8):2571-2580.DOI:10.1016/j.bbagen.2014.03.007.
相似文献/References:
[1]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝组织MMP-1、MMP-2、TIMP-1的表达与预后研究[J].临床小儿外科杂志,2007,6(01):5.
[2]毛永忠,汤绍涛,阮庆兰,等.胆道闭锁肝脏组织MMP-2、TGF-β_1的表达及意义[J].临床小儿外科杂志,2007,6(03):5.
[3]余梦楠 刘钢 黄柳明 王伟. 胆道闭锁术后反复发作性胆管炎的细菌谱分析及抗生素选择[J].临床小儿外科杂志,2012,11(03):187.
[J].Journal of Clinical Pediatric Surgery,2012,11(08):187.
[4]董淳强 杨体泉 董昆. 胆道闭锁术后早期胆管炎风险因素分析[J].临床小儿外科杂志,2013,12(05):348.
[5]陈功 郑珊 孙松. 不同年龄胆道闭锁患儿手术效果分析[J].临床小儿外科杂志,2014,13(01):22.
[6]谭梅军 陶强 黄金狮. IL-17在胆道闭锁患儿肝组织中的表达及意义[J].临床小儿外科杂志,2014,13(04):302.
[7]杨文萍 吴艳 张守华. 胆道闭锁患者肝脏组织病理改变的综合评价[J].临床小儿外科杂志,2015,14(01):10.
[8]李康 阳历 汤绍涛. 胆道闭锁患者肝内胆管γδT 细胞和调节性T细胞浸润及意义[J].临床小儿外科杂志,2015,14(01):16.
[9]刘丹丹 詹江华 高伟. 胆道闭锁患者肝门的病理解剖学研究[J].临床小儿外科杂志,2015,14(01):20.
[10]张震 李龙 乔国梁. 胆道闭锁Kasai术后生存率及条件生存率分析[J].临床小儿外科杂志,2015,14(01):25.
备注/Memo
收稿日期:2024-5-30。
基金项目:2020年度国家中心自主设计项目(SZOC0004)
通讯作者:钭金法,Email:toujinfa@zju.edu.cn